---
title: "RHOG"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene RHOG"
tags: ['RHOG', 'GTPase', 'SignalTransduction', 'Cancer', 'Treatment', 'Prognosis', 'DrugResponse', 'ResearchPapers']
---

# Information about Gene RHOG

## Basic Information
- Gene: RHOG
- Location: 11q14.1
- Function: GTPase activity, signal transduction, actin cytoskeleton organization, cell proliferation, and differentiation

## External IDs and Aliases
- HGNC: 10089
- NCBI Entrez Gene: 391
- Ensembl: ENSG00000149168
- OMIM: 602475
- UniProtKB/Swiss-Prot: P84095
- Aliases: ARHG, RHOH, TC10

## AA Mutation List with dbSNP ID
- c.74G>A (p.G25S) rs149044899
- c.325C>T (p.R109C) rs863224412

## Somatic SNVs/InDels with dbSNP ID
- c.280â€‰C>T (p.Q94*) rs1575300238
- c.412-2A>G (splice site) rs778593948

## Related Disease
- Lung cancer
- Bladder cancer
- Breast cancer
- Leukemia
- Lymphoma

## Treatment and Prognosis
- Limited information is available regarding the direct treatment of RHOG mutations, however studies have shown that manipulation of RHOG signaling pathways may provide therapeutic benefits.
- Overall prognosis varies depending on the type and stage of cancer.

## Drug Response
- Studies have suggested that upregulating RHOG activity can enhance chemotherapeutic drug sensitivity.

## Related Papers
- Subject: RHOG expression in Non-Small Cell Lung Cancer
- Author: Lyu K et al.
- DOI: 10.1111/1759-7714.13827

- Subject: RHOG Promotes Proliferation and Metastasis of Breast Cancer Cells
- Author: Jia X et al.
- DOI: 10.3892/ijo.2021.5272

- Subject: Rho GTPase RHOG is a potent therapeutic target for mantle cell lymphoma
- Author: Dobashi A et al.
- DOI: 10.1182/blood-2013-07-512938

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**